#USA #New York #Mount Sinai #jscreen #TODAY Show

Major Cancer Genetic Screening Event

In an inspiring collaboration to mark Breast Cancer Awareness Month, jscreen.org, a national nonprofit organization dedicated to making genetic testing accessible, teamed up with Myriad Genetics and Mount Sinai Cancer Center. On October 3, 2025, these organizations hosted an unprecedented event on Rockefeller Plaza, attracting 350 participants who signed up for genetic screening during the historic Pink Power Hour at the TODAY Show Plaza.

A Groundbreaking Initiative

This event achieved a remarkable milestone with the largest number of people registered for genetic testing in just one hour, thanks to the generous funding from jscreen's supporters and the philanthropic contributions from Mount Sinai. The collaboration offered all 350 hereditary cancer screenings at no cost to the participants who registered on-site, exemplifying the commitment to making crucial health resources available to the public.

This initiative effectively shed light on the vital role of genetic testing, emphasizing prevention and early detection in the fight against cancer. By empowering individuals with knowledge about their inherited cancer risks, attendees were encouraged to make proactive health choices, which can lead to life-saving outcomes.

Spreading Awareness Nationwide

The primary goal of the event was not only to facilitate screenings but also to inspire a nationwide movement toward hereditary cancer testing. By providing at-home genetic test kits on-site, jscreen rallied participants to understand their potential risks for cancers associated with mutations in BRCA1, BRCA2, and numerous other cancer-related genes.

“Knowledge is power when it comes to health. We strive to eliminate barriers and offer this opportunity during Breast Cancer Awareness Month,” stated Dr. Matt Goldstein, CEO of jscreen. “This landmark event demonstrates how one simple test can change and even save lives.”

The event featured notable appearances from breast cancer advocate and TODAY Show contributor Jill Martin and Dr. Elisa Port, Chief Breast Surgeon at Mount Sinai. Their involvement highlighted the significance of early detection and genetic testing, reinforcing the mission of turning personal challenges into a broader movement for empowerment and prevention.

A Powerful Partnership for Public Health

Jscreen, as a national nonprofit, aims to enhance accessibility to high-quality hereditary cancer and reproductive genetic testing. Through education, outreach, and telehealth counseling services, they seek to make testing affordable and straightforward, empowering individuals and families to take preventive measures against hereditary cancers.

The TODAY Show, America’s leading morning broadcast, amplified awareness of hereditary cancer risks, reaching millions of homes across the nation. Its extensive coverage and support of the event played a crucial role in inspiring viewers to understand the importance of pursuing genetic testing.

Mount Sinai Cancer Center, recognized as one of the top cancer institutions in the country, contributed by underwriting the cost of screenings and providing expert knowledge through a team of genetic counselors who were on site to educate attendees on the lifesaving benefits of early detection.

How to Access Genetic Testing

Individuals across the U.S. can access hereditary cancer genetic testing by visiting jscreen.org, using Myriad Genetics' MyRisk® Hereditary Cancer Test. This initiative aims to inform public health and empower individuals through accessible testing and expert resources, promoting a proactive approach to health management.

Learn More

For further insights about the efforts of jscreen, Myriad Genetics, and Mount Sinai in enhancing public health and awareness, we encourage readers to explore their respective websites and stay informed about upcoming events and available testing options. Together, these efforts spotlight the collective responsibility in the ongoing battle against cancer.